Although studies have also demonstrated a partial function of m6A modification in cervical cancer (CC) [12, 14, 17, 18], our understanding of the regulatory mechanism and how m6A regulator proteins synergistically induce specific tumor malignant phenotype is largely unknown. This evidence concerns the gene METTL3 and neoplasm.